TCTR20210401005
Not yet recruiting
Phase 3
A comparison between Platelet rich plasma injection and conventional steroid injection for the treatment of Lumbar facet joint arthritis, A randomized controlled trial study.
Ratchadapisek Research Funds0 sites30 target enrollmentApril 1, 2021
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- patient with low back pain who was diagnosed as lumbar facet joint pain requiring lumbar facet injection
- Sponsor
- Ratchadapisek Research Funds
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •more than 18 years old
- •well\-controlled underlying disease
- •diagnosed as facet joint arthritis or facet joint pain
- •able to follow up at OPD pain at least 6 month after intervention
Exclusion Criteria
- •patient who cannot co\-operation or communication
- •patient with bone metastasis or cancer with unstable condition
- •sepsis or active infection at site of intervention
- •immunocompromized patient
- •patient who has related drug allergic history
- •pregnant patient
- •coagulation problems or cannot stop or delay the anticoagulant or antiplatelet medication
- •patient who refuse to do the intervention or PRP
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effect of platelet rich plasma on treatment of knee osteoarthritisknee osteoarthritis.Primary gonarthrosisIRCT2012110611382N1Research sector of Tehran University Of Medical Sciences54
Completed
Phase 2
Platelet Rich Plasma infiltration for Hip BursitisTrochanteric bursitisM70.6RBR-82gqqkFaculdade de Ciências Médicas da Santa Casa de São Paulo
Not yet recruiting
Phase 4
Comparison of Platelet Rich Fibrin, Platelet Rich Plasma and mineral trioxide aggregate as pulpotomy agents in primary mandibular molarsCTRI/2024/06/068937DrAman Kumar
Not yet recruiting
Phase 1
Comparison of two plasma derivates as pulpotomy agents in human immature molarsCTRI/2020/06/025938Terna Dental College
Not yet recruiting
Phase 3
comparison of two drugs in oral sub mucous fibrosisHealth Condition 1: - Health Condition 2: R478- Other speech disturbancesCTRI/2022/10/046263Dr Ajay Kumar60